News

In a recent study, children aged 5 to 11 years were less likely to be hospitalized with the Omicron strand if they received vaccination against COVID-19.

In a recent study, penicillin allergy documentation was uninformative in allergy tabs, and children were not often referred to allergists.

Covis, the manufacturer of the controversial preterm birth prevention drug Makena, has announced it will voluntarily withdraw the drug from the market after recommendations from the Center for Drug Evaluation and Research.

In a recent study, the prevalence of e-cigarette use was greater among sexual minority youth than heterosexual or questioning youth.

In a recent study, a poor connection was reported between mental health emergency department discharge and follow-ups through outpatient care.

A supplemental New Drug Application for empagliflozin (Jardiance; Boehringer Ingelheim and Eli Lilly and Company) in pediatric patients with type 2 diabetes has been accepted by the FDA.

In a recent study, the risk of death from respiratory diseases during adulthood almost doubled in individuals who experienced a lower respiratory tract infection at a young age.

Following positive results from a phase 3 clinical trial, the FDA has accepted a New Drug Application for berdazimer gel, 10.3% (Novan) for treating patients with molluscum contagiosum.

Children were hospitalized the most during the Omicron variant, but disease outcomes were the least severe during this variant period.

In a new policy statement, the American Academy of Pediatrics has provided guidelines on reducing crowding in emergency departments.

In a recent study, the rate of suicidal ideation was 1.7 times greater among adolescents with depression who had experienced a violent encounter in the past year.

Data from AAAAI 2023 suggests that gut microbial composition, function, and metabolic activity are implicated in the efficacy of peanut oral immunotherapy in children with peanut allergy.

In a recent study, worse neurodevelopmental outcomes were seen in children born preterm and with postnatal growth failure.

Velmanase alfa-tycv (Lamzede, Chiesi Global Rare Diseases) has received approval by the FDA for treating alpha-mannosidosis in adult and pediatric patients.

From AI-powered symptom checking to virtual intake tools, recent technological advances hold promise for enhancing care delivery.

Results of a recent review showed that adalimumab, etanercept, golimumab, and infliximab are effective and well-tolerated treatments options for patients with juvenile idiopathic arthritis.

Omaveloxolone (SKYCLARYS, Reata Pharmaceuticals) has received FDA approval for treating Friedreich’s ataxia in patients aged 16 years and older.

In a recent report from the CDC, monovalent vaccines from Moderna and Pfizer have shown vaccine effectiveness in children aged 3 to 5 years in at least the first 4 months after vaccination.

A new drug application for VP-102 for treating molluscum contagiosum has been accepted by the FDA.

In a recent study, rates of suicide during the COVID-19 pandemic were higher among youths aged 5 to 24 years than expected based on trends prior to the pandemic.

In data presented at the AAAAI annual conference, 5 common contact dermatitis-causing allergens were identified, emphasizing the importance of patch testing.

In a recent study, ultrasound radiomics showed effective predictive ability for extrathyroidal extension (ETE) in pediatric papillary thyroid cancer (PTC).

A recent report from the CDC detailed increasing rates of sadness and violence among US teenage girls.

A recent report from the Centers for Disease Control and Prevention outlined rates of fruit, vegetable, and sugary drink intake among young children by state.

A booster dose of mRNA COVID-19 vaccination during pregnancy increases protection of infants from infection and related hospitalization.

A recent poll from the C.S. Mott Children’s Hospital National Poll on Children’s Health showed how parents respond to potential fever in their children.

Investigators stress the need for timely surgical intervention to ensure favorable visual outcomes in patients with severe complications, including retinal detachment and vitreous hemorrhage.

Read the latest medications for pediatric patients approved by the US Food and Drug Administration.